Literature DB >> 12098066

T cell infiltration and chemokine expression: relevance to the disease localization in murine graft-versus-host disease.

J Y New1, B Li, W P Koh, H K Ng, S Y Tan, E H Yap, S H Chan, H Z Hu.   

Abstract

Acute graft-versus-host disease (GVHD) involves mainly skin, liver and intestines. Other organs such as heart, muscle and central nervous system are seldom affected, although their parenchymal cells also express alloantigens, such as MHC class I antigens. The mechanism of this selective involvement of distinct organs in acute GVHD is not well understood. We postulated that it might be related to the selective migration of activated alloreactive T cells. Indeed, T cell infiltration, revealed by examination of serial samples using flow cytometry and immunohistology, occurred early and continuously in the target organs such as the liver, but not in a non-target organ, the heart, in a murine acute GVHD model. Since T cell migration is largely controlled by the expression of chemokine and chemokine receptors, we investigated the chemokine spectrum in target/non-target organs of mice with acute GVHD. We found that in the spleen and liver MIP-1alpha, MIP-2 and Mig were the predominant chemokines expressed. In another target organ, the skin, MIP-1alpha, MIP-2, MCP-1 and MCP-3 were all highly expressed. In a non-target organ of acute GVHD, the heart, the predominant chemokines expressed were MCP-1 and MCP-3. This distinct pattern of chemokine expression in these organs may contribute to the preferential recruitment of inflammatory cells into the liver and skin, but not into the heart, in acute GVHD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12098066     DOI: 10.1038/sj.bmt.1703563

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  23 in total

1.  Blockade of osteopontin reduces alloreactive CD8+ T cell-mediated graft-versus-host disease.

Authors:  Fang Zhao; Yi Zhang; Hao Wang; Min Jin; Shan He; Yufang Shi; Yajun Guo; Yanyun Zhang
Journal:  Blood       Date:  2010-11-30       Impact factor: 22.113

2.  Dynamics of early histopathological changes in GVHD after busulphan/cyclophosphamide conditioning regimen.

Authors:  Sulaiman Al-Hashmi; Zuzana Hassan; Behnam Sadeghi; Björn Rozell; Moustapha Hassan
Journal:  Int J Clin Exp Pathol       Date:  2011-07-31

3.  Ectopic lymphoid tissue formation in the lungs of mice infected with Chlamydia pneumoniae is associated with epithelial macrophage inflammatory protein-2/CXCL2 expression.

Authors:  P M Fitch; N M Wheelhouse; P Bowles; M Paterson; D Longbottom; G Entrican; S E M Howie
Journal:  Clin Exp Immunol       Date:  2010-09-14       Impact factor: 4.330

4.  Preventive usage of broad spectrum chemokine inhibitor NR58-3.14.3 reduces the severity of pulmonary and hepatic graft-versus-host disease.

Authors:  Sandra Miklos; Gunnar Mueller; Yayi Chang; Abdellatif Bouazzaoui; Elena Spacenko; Thomas E O Schubert; David J Grainger; Ernst Holler; Reinhard Andreesen; Gerhard C Hildebrandt
Journal:  Int J Hematol       Date:  2009-03-14       Impact factor: 2.490

5.  Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group.

Authors:  Hisaki Fujii; Geoff Cuvelier; Kevin She; Soudabeh Aslanian; Hiromi Shimizu; Amina Kariminia; Mark Krailo; Zhengjia Chen; Rob McMaster; Axel Bergman; Frederick Goldman; Stephen A Grupp; Donna A Wall; Andrew L Gilman; Kirk R Schultz
Journal:  Blood       Date:  2007-10-09       Impact factor: 22.113

6.  Reciprocal function of Galphai2 and Galphai3 in graft-versus-host disease.

Authors:  Yong Zhu Jin; Brian D Thompson; Zho Yan Zhou; Yineng Fu; Lutz Birnbaumer; Mei X Wu
Journal:  Eur J Immunol       Date:  2008-07       Impact factor: 5.532

7.  IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease.

Authors:  David Polchert; Justin Sobinsky; Gw Douglas; Martha Kidd; Ada Moadsiri; Eduardo Reina; Kristyn Genrich; Swati Mehrotra; Suman Setty; Brett Smith; Amelia Bartholomew
Journal:  Eur J Immunol       Date:  2008-06       Impact factor: 5.532

8.  Tumor vaccines expressing flt3 ligand synergize with ctla-4 blockade to reject preimplanted tumors.

Authors:  Michael A Curran; James P Allison
Journal:  Cancer Res       Date:  2009-09-08       Impact factor: 12.701

9.  ShiA abrogates the innate T-cell response to Shigella flexneri infection.

Authors:  Molly A Ingersoll; Arturo Zychlinsky
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

Review 10.  Graft-versus-leukemia effect of nonmyeloablative stem cell transplantation.

Authors:  Masahiro Imamura; Junji Tanaka
Journal:  Korean J Intern Med       Date:  2009-11-27       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.